InventisBio Co., Limited (SHA:688382)
China flag China · Delayed Price · Currency is CNY
23.60
-0.12 (-0.51%)
At close: May 23, 2025, 2:57 PM CST

InventisBio Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
17,3857,6718,7067,636--
Upgrade
Market Cap Growth
90.50%-11.89%14.01%---
Upgrade
Enterprise Value
15,7756,0716,7285,265--
Upgrade
Last Close Price
30.0613.3015.1413.28--
Upgrade
PS Ratio
103.2545.4546.92---
Upgrade
PB Ratio
9.824.244.363.45--
Upgrade
P/TBV Ratio
9.824.244.363.45--
Upgrade
EV/Sales Ratio
93.6935.9736.27---
Upgrade
Debt / Equity Ratio
0.010.010.010.010.04-
Upgrade
Asset Turnover
0.090.080.08---
Upgrade
Quick Ratio
22.4420.6513.2920.177.3722.52
Upgrade
Current Ratio
22.5920.7813.4120.417.5022.64
Upgrade
Return on Equity (ROE)
-11.58%-12.61%-13.48%-33.34%-42.22%-208.94%
Upgrade
Return on Assets (ROA)
-8.04%-8.60%-9.08%-20.63%-24.42%-115.73%
Upgrade
Return on Capital (ROIC)
-8.50%-9.14%-9.63%-22.00%-26.38%-127.58%
Upgrade
Earnings Yield
-1.23%-3.13%-3.26%-6.33%--
Upgrade
FCF Yield
-1.29%-3.25%-3.61%-6.35%--
Upgrade
Buyback Yield / Dilution
0.78%-0.26%-12.97%-10.91%0.25%-
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.